Cell-cycle disruptions and apoptosis induced by the cyclophosphamide derivative mafosfamide
Related Experiment Video
Updated: Nov 8, 2026

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
1Department of Haematology, School of Pathology of the University of the Witwatersrand, South Africa.
Abstract:
The effect of the cyclophosphamide derivative mafosfamide (ASTA Z 7557) was investigated in vitro in HL60 leukemic cells. Mafosfamide, which rapidly generates 4-hydroxycyclophosphamide after aqueous dissolution, was employed at doses ranging from 0.1 to 10 micrograms/mL. In unsynchronized cells, mafosfamide exposure was associated with an S-phase accumulation, a suggestion of a G2-phase arrest and morphological and biochemical evidence of apoptosis. In cells that had been synchronized by the double thymidine block method, S-phase progression was considerably delayed in the presence of mafosfamide. The apoptosis that was evident in mafosfamide-treated cells 12 hours after release from the thymidine block was found to occur in the presence of S-phase and G2-phase cell-cycle arrests. Taken together, the current data suggest that mafosfamide may have potential synergism with other anticancer agents that elicit similar cell-cycle arrests as well as with chemotherapeutic drugs that activate the apoptotic cascade.
Insights
Mafosfamide, a cyclophosphamide derivative, induces apoptosis and cell cycle arrest in leukemic cells. This suggests potential synergistic effects when combined with other anticancer agents.
Area of Science:
- Pharmacology
- Cell Biology
- Oncology
Background:
- Cyclophosphamide derivatives are crucial in cancer chemotherapy.
- Understanding the mechanisms of action of novel agents like mafosfamide is essential.
Purpose of the Study:
- To investigate the in vitro effects of mafosfamide (ASTA Z 7557) on HL60 leukemic cells.
- To determine the impact of mafosfamide on cell cycle progression and apoptosis.
Main Methods:
- Exposure of HL60 cells to varying doses of mafosfamide (0.1-10 µg/mL).
- Cell cycle analysis using methods like double thymidine block.
- Morphological and biochemical assessment of apoptosis.
Main Results:
- Mafosfamide induced S-phase accumulation and suggested G2-phase arrest in unsynchronized cells.
- Apoptosis was observed in mafosfamide-treated cells, occurring alongside S-phase and G2-phase cell cycle arrests.
- Significant delay in S-phase progression was noted in synchronized cells.
Conclusions:
- Mafosfamide triggers apoptosis and cell cycle arrest in leukemic cells.
- Potential for synergistic activity of mafosfamide with other anticancer drugs that induce similar cell cycle arrests or apoptosis.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
Mitogens and the Cell Cycle
Anaphase Promoting Complex
